Optimal age and outcome measures for Alzheimer's disease prevention trials in people with Down syndrome. (2021)

First Author: Hithersay R
Attributed to:  Computational models for clinical trial design in Huntington's disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/alz.12222

PubMed Identifier: 33226718

Publication URI: http://europepmc.org/abstract/MED/33226718

Type: Journal Article/Review

Volume: 17

Parent Publication: Alzheimer's & dementia : the journal of the Alzheimer's Association

Issue: 4

ISSN: 1552-5260